A handful of startups are betting that more efficient electric and hybrid propulsion will open up new markets around the world for water-based aviation.
Robinson Helicopter’s tie-up with United Therapeutics to develop a hybrid-electric version of the R66 is a sign of new CEO David Smith’s drive for innovation.
United Therapeutics’ founding objective to manufacture artificial organs and overcome the critical shortage of human organs for transplant is nearing takeoff.
While AAM will get its start using existing heliports and private terminals at airports, dedicated vertiport infrastructure is beginning to take shape.
Although shareholders have put more money into advanced air mobility, getting government loans could still be crucial, and avoiding program delays will be key.
The aircraft will rival the carrying capacity of the largest civilian helicopters but with lower operating costs and a far superior noise and emissions footprint.